Mizuguchi H, Nakanishi M, Nakanishi T, Nakagawa T, Nakagawa S, Mayumi T
Faculty of Pharmaceutical Science, Osaka University, Japan.
Br J Cancer. 1996 Feb;73(4):472-6. doi: 10.1038/bjc.1996.83.
Previously we reported that fusogenic liposomes, prepared by fusing simple liposomes with Sendai virus particles, could introduce their contents directly and efficiently into the cytoplasm. In this study, we examined the anti-tumour activity of fusogenic liposomes containing fragment A of diphtheria toxin (DTA). Fusogenic liposomes containing DTA showed high cytotoxicity against sarcoma-180 (S-180) cells in vitro. When these liposomes were administered into the abdominal cavity of ddY mice carrying S-180, tumour cells completely disappeared in four of six tumour-bearing mice without decrease in body weight. Neither simple liposomes containing DTA nor empty fusogenic liposomes had any effect on tumour suppression. We conclude that fusogenic liposomes containing DTA are new and potentially effective tools for the treatment of ascites tumours without any severe side-effects.
此前我们报道过,通过将简单脂质体与仙台病毒颗粒融合制备的融合脂质体能够直接且高效地将其内容物导入细胞质。在本研究中,我们检测了含有白喉毒素A片段(DTA)的融合脂质体的抗肿瘤活性。含有DTA的融合脂质体在体外对肉瘤-180(S-180)细胞表现出高细胞毒性。当将这些脂质体注入携带S-180的ddY小鼠腹腔时,六只荷瘤小鼠中有四只的肿瘤细胞完全消失,且体重未减轻。含有DTA的简单脂质体和空的融合脂质体对肿瘤抑制均无任何作用。我们得出结论,含有DTA的融合脂质体是治疗腹水肿瘤的新型且潜在有效的工具,且无任何严重副作用。